The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
Verity Hill(Yale University), Andrew Rambaut(Institut de Biologia Evolutiva), Ian Goodfellow(University of Cambridge), John T. McCrone(University of Edinburgh), Nicholas J. Loman(University of Birmingham), Thomas P. Peacock(The Pirbright Institute), Thomas R. Connor(Wellcome Sanger Institute), Joel Southgate(Cardiff and Vale University Health Board), Emily Scher(University of Edinburgh), Ravindra K. Gupta(Johns Hopkins University), William Barclay(NIHR Imperial Biomedical Research Centre), Jeffrey C. Barrett(Wellcome Sanger Institute), Anna Price(University of Exeter), Alessandro M. Carabelli(University of Nottingham), Erik Volz(London Centre for Neglected Tropical Disease Research), Dinesh Aggarwal(University of Cambridge), Oliver G. Pybus(Oxford Research Group), Richard Myers(Public Health England), Áine O’Toole(University of Edinburgh), Natalie Groves(Public Health England), Meera Chand(St Thomas' Hospital), Eileen Gallagher, Rachel Colquhoun(University of Edinburgh), David L. Robertson(MRC University of Glasgow Centre for Virus Research), Ben Jackson(University of Edinburgh), Nicholas Ellaby(UK Health Security Agency), Theo Sanderson(The Francis Crick Institute), Ewan M. Harrison(Wellcome Sanger Institute), Louis du Plessis(University of Oxford)
Cited by 166
Related Papers
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
|Nature|2007|9.6k
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
|Nature Microbiology|2020|3k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.7k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k